Share
1,521 Posts.
lightbulb Created with Sketch. 203
clock Created with Sketch.
06/10/21
16:44
Share
Originally posted by malairtiche:
↑
All I can say is, CFO better have a good quarterly wrap-up with the kiln and be on track for final commissioning during this dec qtr. So I have 2 scenario thoughts, place your bets either way really... 1) Bad qtrly eg. delay with the kiln, thereby delay with final commissioning going into new year. 2) Good qtrly eg. ahead with kiln and ann of final commissioning shortly thereafter and ahead of schedule. SP suggesting scenario 1 to me. Even if the kiln side is a dud, let's hope it's a salvageable dud that another party may be interested in pursuing further as it is a tremendously innovative product. If not, Innovaero will be a solid revenue platform eventually. dyor. Nonetheless, I'm still keen to retain my small (in the red!) parcel and ride this 'foamfox'. Thankyou
Expand
Totally agree with your scenario 1 prediction. As for the innovaero, IMO, don't hold too high hope on that, because it seems to me that they trying to wait for the undiluted interest clause to lapse before they go IPO. What I heard from Biotrader the initial IPO was planned for September and it has passed. DYOR